Fort Washington Investment Advisors Inc. OH Sells 45,082 Shares of HCA Healthcare, Inc. $HCA

Fort Washington Investment Advisors Inc. OH trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 187,628 shares of the company’s stock after selling 45,082 shares during the period. Fort Washington Investment Advisors Inc. OH owned 0.08% of HCA Healthcare worth $87,596,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. Sovran Advisors LLC grew its holdings in HCA Healthcare by 1.0% during the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after purchasing an additional 22 shares during the period. Centerpoint Advisors LLC boosted its stake in shares of HCA Healthcare by 11.0% during the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after acquiring an additional 22 shares during the period. Cary Street Partners Financial LLC raised its stake in HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after acquiring an additional 22 shares during the period. Angeles Wealth Management LLC boosted its position in HCA Healthcare by 2.4% during the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock worth $432,000 after purchasing an additional 24 shares during the period. Finally, One Capital Management LLC raised its position in shares of HCA Healthcare by 1.1% in the third quarter. One Capital Management LLC now owns 2,250 shares of the company’s stock valued at $959,000 after purchasing an additional 24 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares in the company, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 15,214 shares of company stock worth $7,797,595. 1.50% of the stock is owned by company insiders.

Analyst Ratings Changes

HCA has been the topic of a number of research reports. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Jefferies Financial Group lifted their price target on HCA Healthcare from $535.00 to $590.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Mizuho increased their price objective on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $480.22 on Friday. The stock has a market capitalization of $107.36 billion, a PE ratio of 16.92, a P/E/G ratio of 1.49 and a beta of 1.34. HCA Healthcare, Inc. has a fifty-two week low of $314.43 and a fifty-two week high of $556.52. The business has a fifty day moving average price of $510.62 and a two-hundred day moving average price of $475.16.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.HCA Healthcare’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the business earned $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.